Log in to save to my catalogue

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-sp...

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-sp...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c80de718941446dfb6c9665174400e1e

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

About this item

Full title

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

Publisher

London: Nature Publishing Group UK

Journal title

Translational psychiatry, 2022-10, Vol.12 (1), p.457-457, Article 457

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A significant proportion of the personal and economic burden of schizophrenia can be attributed to the late diagnosis or misdiagnosis of the disorder. A novel, objective diagnostic approaches could facilitate the early detection and treatment of schizophrenia and improve patient outcomes. In the present study, we aimed to identify robust schizophre...

Alternative Titles

Full title

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c80de718941446dfb6c9665174400e1e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c80de718941446dfb6c9665174400e1e

Other Identifiers

ISSN

2158-3188

E-ISSN

2158-3188

DOI

10.1038/s41398-022-02229-w

How to access this item